US Stocks Jumped on M&A Rumor (AGN, BIIB, GENZ)

Today, three large cap Biotech companies’ shares have soared in the morning session after According to a report early Friday by Bloomberg News, Sanofi's chief executive officer has informed the Sanofi's board that the company was in preliminary negotiations to acquire a U.S.-based drug maker for around $20 billion.

Subscribe to daily free stock newsletter by visiting:  http://www.pennystockpickreport.com/

Genzyme, Biogen and Allergan are conserving to be a strong option.

Allergan, Inc. (Public, NYSE:AGN) shares soared 8.62% to $63.11 on very heavy volume after climbing as much as 11.50% earlier in the session.

So far this year, the stock has a flat YTD and has a 52-week range of $44.78-$65.87.

Allergan, Inc.is a multi-specialty health care company focused on developing and commercializing pharmaceuticals, biologics and medical devices.

Biogen Idec Inc. (Public, NASDAQ:BIIB) climbed 4.55% to $48.86 after hitting a day’s high of $50.91.

So far this year, the stock has fallen over 8.50% and has a 52-week range of $41.75-$60.28.

Subscribe to daily free stock newsletter by visiting:  http://www.pennystockpickreport.com/

Shares of Genzyme Corporation (Public, NASDAQ:GENZ) is among the most active stocks and gained 4.75% to $52.25 after rising as much as 9% earlier in the session.

So far this year, the stock has risen over 4% and has a 52-week range of $45.39-$60.15.

Genzyme Corporation (Genzyme) is a biotechnology company. The Company’s product and service portfolio is focused on rare genetic disease disorders, renal diseases, orthopaedics, cancer, transplant and immune disease.

About http://www.pennystockpickreport.com/

Penny Stock Pick Report offers stock newsletter on OTC, PINKSHEETS ,OTCBB, AMEX, NASDAQ and NYSE stock exchange. Our subscribers receive daily up to date stock information on hot stocks, most active movers, top gainers, penny stocks and much more. If you wish to feature your organization on our website then you can contact us at the email given below.